2026 NPPES data Radiation Oncology Physician NPI 1275631293 M.D., MPSA, MBA
Verify on CMS →

Nora Janjan, M.D., MPSA, MBA

Radiation Oncology Physician in Navasota, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,141 in Radiation Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
68
Medicare Part D claims · Radiation Oncology Physician avg: 135
Generic prescribing
74%
generic claims · 26% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

Nora Janjan, M.D., MPSA, MBA filed 68 Medicare Part D claims in 2024 as a Radiation Oncology Physician in Navasota, Texas, prescribing 74% generic.

68
Part D claims, 2024
74%
generic prescribing
≥0th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Nora Janjan, M.D., MPSA, MBA

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1275631293), first enumerated 09/21/2006.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 68 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.

    Source: NUCC taxonomy + CMS participation heuristic

  • State context

    State board disciplinary context

    Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Nora Janjan, M.D., MPSA, MBA's individual license status. Verify directly with the state medical board.

    Source: TMB annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1275631293 · Radiation Oncology Physician

NPI-10 · ENUM-LEGACY · TAX-MID · RX-TRACE · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1275631293
  • ENUM-LEGACY 2006
  • TAX-MID 6K Radiation Oncology
  • RX-TRACE 68
  • BOOK-THIN 392 in Texas
  • PHOTO-ENUM Albert Lee · 2006

Nora Janjan, M.D., MPSA, MBA's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

68 ≥ 0th percentile 0% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). This entry sits in this band. 200–400: 188,835 prescribers (13%). Above this entry. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board-eligible specialty (heuristic, not verified)

Nora Janjan, M.D., MPSA, MBA practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Nora Janjan, M.D., MPSA, MBA?

Quality data not reported

NPI registry status

Active

Issued 09/21/2006

NPI 1275631293

Primary specialty

Radiation Oncology Physician

Mid-sized

6,141 US NPIs in this specialty

Medicare Part D claims

68 50% vs specialty avg

2024 prescription claims

Specialty avg: 135

Specialty distribution in Texas

How Radiation Oncology Physician compares to other specialties among Texas providers

Texas providers
Behavior Technician6%Student in an Organized Heal…5.3%Family Nurse Practitioner4.5%Professional Counselor4.4%Pharmacist4.3%Speech-Language Pathologist3.9%Radiation Oncology Physician0.1%
Largest specialties in Texas (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Radiation Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

14446 HIGHWAY 6
Navasota, TX 77868

Provider Details

NPI 1275631293
Specialty Radiation Oncology Physician
Credentials M.D., MPSA, MBA
Gender Female
NPI Issued 09/21/2006

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Nora Janjan, M.D., MPSA, MBA. To verify Nora Janjan, M.D., MPSA, MBA's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Nora Janjan, M.D., MPSA, MBA - brand share 26.0%
Radiation Oncology Physician average

26% brand-name claims vs 74% generic, on 68 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

68
Total Claims
$8K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
84
Total Day Supply
2,495
Brand vs Generic
26% brand / 74% generic
Brand Drug Cost
$7K
Generic Drug Cost
$1K

Patient Demographics

Average Patient Age
76.5 years
Avg HCC Risk Score
1.32

Radiation Oncology Physician Overview

How Nora Janjan, M.D., MPSA, MBA fits within the Radiation Oncology Physician landscape nationally.

6,141
Radiation Oncology Physician Providers in US
53
States with Radiation Oncology Physician
135
Avg Claims per Provider

Nora Janjan, M.D., MPSA, MBA's 68 claims are below the specialty average of 135.

Nationwide Radiation Oncology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Janjan, both outside Texas so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Radiation Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Janjan.

One of 392 Radiation Oncology Physician providers enrolled in Texas, 5 are shown here.

Compare Radiation Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Nora Janjan, M.D., MPSA, MBA's specialty?
Nora Janjan, M.D., MPSA, MBA specializes in Radiation Oncology Physician and practices in Navasota, Texas. Credentials: M.D., MPSA, MBA.
How much does Nora Janjan, M.D., MPSA, MBA prescribe under Medicare Part D?
In 2024, Nora Janjan, M.D., MPSA, MBA wrote 68 Medicare Part D claims totaling $8K in drug costs for N/A beneficiaries.
Where is Nora Janjan, M.D., MPSA, MBA located?
Nora Janjan, M.D., MPSA, MBA is located at 14446 HIGHWAY 6, Navasota, TX, 77868. Phone: (936) 825-9257.
What is Nora Janjan, M.D., MPSA, MBA's NPI number?
Nora Janjan, M.D., MPSA, MBA's National Provider Identifier (NPI) is 1275631293, issued on 09/21/2006.
Does Nora Janjan, M.D., MPSA, MBA prescribe more brand-name or generic drugs?
Nora Janjan, M.D., MPSA, MBA's prescribing is 26% brand-name and 74% generic drugs by claim count, with $7K in brand drug costs.
How many Radiation Oncology Physician providers are there in the US?
There are 6,141 Radiation Oncology Physician providers across 53 states in the US. The average Radiation Oncology Physician provider writes 135 Medicare Part D claims per year.
Does Nora Janjan, M.D., MPSA, MBA accept Medicare?
Nora Janjan, M.D., MPSA, MBA appears in CMS Medicare data with 68 Part D claims and N/A Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Nora Janjan, M.D., MPSA, MBA's credentials?
Nora Janjan, M.D., MPSA, MBA's NPI is 1275631293 with credentials M.D., MPSA, MBA. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.